WallStreetZenWallStreetZen

NASDAQ: NLSP
Nls Pharmaceutics Ltd Stock

Open Broker Account
$0.96+0.11 (+12.94%)
Updated Dec 5, 2022
NLSP Price
$0.96
Fair Value Price
$1.09
Market Cap
$17.07M
52 Week Low
$0.33
52 Week High
$2.40
P/E
-0.86x
P/B
-4.22x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$15.98M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.51
Operating Cash Flow
-$13M
Beta
0.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NLSP Overview

NLS Pharmaceutics AG is developing therapies for patients with rare and complex central nervous system disorders (e.g., narcolepsy, idiopathic hypersomnia, and other rare sleep disorders), as well as neurodevelopmental disorders (e.g, attention deficit hyperactivity disorder). The company's lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy, and Nolazol for the treatment of ADHD. NLS Pharmaceutics was incorporated in 2015 and is based in Zurich, Switzerland.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NLSP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NLSP ($0.96) is undervalued by 11.75% relative to our estimate of its Fair Value price of $1.09 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NLSP ($0.96) is not significantly undervalued (11.75%) relative to our estimate of its Fair Value price of $1.09 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NLSP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NLSP due diligence checks available for Premium users.

Be the first to know about important NLSP news, forecast changes, insider trades & much more!

NLSP News

Valuation

NLSP fair value

Fair Value of NLSP stock based on Discounted Cash Flow (DCF)
Price
$0.96
Fair Value
$1.09
Undervalued by
11.75%
NLSP ($0.96) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NLSP ($0.96) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NLSP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NLSP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.86x
Industry
14.34x
Market
21.63x

NLSP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-4.22x
Industry
4.96x

NLSP's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
NLSP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$2.1M
Liabilities
$6.1M
Debt to equity
-1.51
NLSP's short-term liabilities ($3.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NLSP's long-term liabilities ($2.69M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NLSP's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NLSP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
NLSP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NLSP vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NLSP$17.07M+13.61%-0.86x-4.22x
BWV$17.11M-3.08%-0.90xN/A
APTX$16.93M-3.47%-0.23x0.35x
MTCR$17.24M+1.00%-0.39x0.47x
JAGX$16.85M-5.69%-0.12x4.62x

Nls Pharmaceutics Stock FAQ

What is Nls Pharmaceutics's quote symbol?

NASDAQ: NLSP) Nls Pharmaceutics trades on the NASDAQ under the ticker symbol NLSP. Nls Pharmaceutics stock quotes can also be displayed as NASDAQ: NLSP.

If you're new to stock investing, here's how to buy Nls Pharmaceutics stock.

What is the 52 week high and low for Nls Pharmaceutics (NASDAQ: NLSP)?

(NASDAQ: NLSP) Nls Pharmaceutics's 52-week high was $2.40, and its 52-week low was $0.33. It is currently -60% from its 52-week high and 190.91% from its 52-week low.

How much is Nls Pharmaceutics stock worth today?

(NASDAQ: NLSP) Nls Pharmaceutics currently has 17,785,920 outstanding shares. With Nls Pharmaceutics stock trading at $0.96 per share, the total value of Nls Pharmaceutics stock (market capitalization) is $17.07M.

Nls Pharmaceutics stock was originally listed at a price of $2.89 in Jan 29, 2021. If you had invested in Nls Pharmaceutics stock at $2.89, your return over the last 1 years would have been -66.78%, for an annualized return of -66.78% (not including any dividends or dividend reinvestments).

How much is Nls Pharmaceutics's stock price per share?

(NASDAQ: NLSP) Nls Pharmaceutics stock price per share is $0.96 today (as of Dec 5, 2022).

What is Nls Pharmaceutics's Market Cap?

(NASDAQ: NLSP) Nls Pharmaceutics's market cap is $17.07M, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nls Pharmaceutics's market cap is calculated by multiplying NLSP's current stock price of $0.96 by NLSP's total outstanding shares of 17,785,920.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.